Exploring Interactions Between Growth Hormone and the Microbiome

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03327207

Enrollment

200

Registered

2017-10-31

Start date

2017-11-01

Completion date

2021-11-30

Last updated

2020-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth Hormone Deficiency

Brief summary

The goal of this study is to characterize the microbiome and metabolomics of children with Growth Hormone (GH) deficiency, prior GH treatment initiation and compare it to healthy children

Interventions

OTHERNon Interventional

Non Interventional

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

3 Years to 18 Years

Inclusion criteria

* Children with GH deficiency

Exclusion criteria

* Turner syndrome * End state renal disease (ESRD) * Prader-Willi syndrome * Systemic illness * Antibiotics/Antifungal in the last 3m

Design outcomes

Primary

Measure	Time frame
Changes in the microbiome population following Growth hormone treatment	1 year

Countries

Israel

Contacts

Primary ContactSmadar Shilo, Dr

smadar.shilo@weizmann.ac.il89344307

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026